Fluvid (True Human COVID-19 antibody therapy )
/ XBiotech
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
June 12, 2025
Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2.
(PubMed, NPJ Vaccines)
- "This vaccine stimulated robust T cell and B cell immune responses and conferred 100% protective efficacy against challenge with either influenza or SARS-CoV-2 viruses in the mouse model, without compromising efficacy compared to administering each monovalent vaccine individually. Our data suggest that the multivalent mRNA vaccine can offer protection against different viruses by generating humoral and cellular responses against multiple antigens at the same time."
Journal • Infectious Disease • Influenza • Novel Coronavirus Disease • Respiratory Diseases
October 31, 2023
A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study).
(PubMed, Vaccine)
- "Adverse events following SIV and COVID-19 co-administration were generally mild and occurred with similar frequency to events following COVID-19 vaccine alone. We found no evidence to justify routine separation of SIV and COVID-19 vaccine doses."
Journal • P4 data • Infectious Disease • Influenza • Novel Coronavirus Disease • Respiratory Diseases
June 17, 2022
"I'll be receiving covaxin for my yearly fluvid shot nothing else inactive virus technology is what's used for the flu shot polio ect why reinvent the wheel???"
(@tazman0128)
May 21, 2022
Validation Of An In-house Real Time PCR Assay For The Simultaneous Detection Of SARS-CoV-2, Influenza A, Influenza B And RSV
(ASM Microbe 2022)
- "The SARS-CoV-2, influenza A/B and RSV assay combines the two targets for SARS-CoV-2 as well as influenza A and B into one channel respectively. This was done to retain RSV as a target. Results for all targets were in high agreement with the corresponding separate assay."
Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
January 05, 2022
"Fluvid is our label name for the Flu A&B/RSV/SARS-CoV-2 combo test."
(@PipettingPlover)
Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
January 05, 2022
"See I don't like ANY name, but fluvid is better than Coronenza, Flurona whatever😄"
(@richdavisphd)
1 to 6
Of
6
Go to page
1